Feedback

Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats

Affiliation
Hunan key laboratory of the research and development of novel pharmaceutical preparations ,Changsha Medical University ,Changsha ,China
Li, Haigang;
Affiliation
Hunan key laboratory of the research and development of novel pharmaceutical preparations ,Changsha Medical University ,Changsha ,China
Zhou, Yi;
Affiliation
Department of Pharmacy ,Changsha Medical University ,Changsha ,China
Liao, Luanfeng;
Affiliation
Center of Clinical Pharmacology ,The Third Xiangya Hospital ,Central South University ,Changsha ,China
Tan, Hongyi;
Affiliation
Center of Clinical Pharmacology ,The Third Xiangya Hospital ,Central South University ,Changsha ,China
Li, Yejun;
Affiliation
Department of medical laboratory ,Changsha Medical University ,Changsha ,China
Li, Zibo;
Affiliation
Department of Pharmacy ,Changsha Health Vocational College ,Changsha ,China
Zhou, Bilan;
Affiliation
Hunan key laboratory of the research and development of novel pharmaceutical preparations ,Changsha Medical University ,Changsha ,China
Bao, Meihua;
Affiliation
Hunan key laboratory of the research and development of novel pharmaceutical preparations ,Changsha Medical University ,Changsha ,China
He, Binsheng

Aim: In China, warfarin is usually prescribed with Chuanxiong Rhizoma for treating thromboembolism diseases. However, the reason for their combination is still being determined. The present study explored the pharmacokinetics interactions of warfarin, Chuanxiong Rhizoma, and gut microbiota in the rat model of middle cerebral artery occlusion (MCAO). Methods: A total of 48 rats were randomly divided into six groups: MCAO rats orally administered warfarin (W group), pseudo germ-free MCAO rats orally administered warfarin (W-f group), MCAO rats co-administered Chuanxiong Rhizoma and warfarin (C + W group), pseudo germ-free MCAO rats co-administered Chuanxiong Rhizoma and warfarin (C + W-f group), MCAO rats co-administered warfarin and senkyunolide I (S + W group); pseudo germ-free MCAO rats co-administered warfarin and senkyunolide I (S + W-f group). After treatment, all animals’ blood and stool samples were collected at different time points. The stool samples were used for 16S rRNA sequencing analysis. Ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) method was established to quantify warfarin, internal standards, and the main bioactive components of Chuanxiong in blood samples. The main pharmacokinetics parameters of warfarin were calculated by DAS 2.1.1 software. Results: The relative abundance of Allobaculum and Dubosiella in the pseudo germ-free groups (W-f, C + W-f, S + W-f) was lower than that in the other three groups (W, C + W, S + W). The relative abundance of Lactobacillus in the W-f group was higher than that of the W group, while the relative abundance of Akkermansia decreased. The relative abundance of Ruminococcaceae _UCG-014 and Ruminococcaceae _NK4A214_group in the S + W-f group was lower than in the S + W group. Compared to the W group, the AUC 0-t and C max of warfarin in the W-f group increased significantly to 51.26% and 34.58%, respectively. The AUC 0-t and C max in the C + W group promoted 71.20% and 65.75% more than the W group. Compared to the W group, the AUC 0-t and C max increased to 64.98% and 64.39% in the S + W group. Conclusion: Chuanxiong Rhizoma and senkyunolide I (the most abundant metabolites of Chuanxiong Rhizoma aqueous extract) might affect the pharmacokinetics features of warfarin in MCAO rats through, at least partly, gut microbiota.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2023 Li, Zhou, Liao, Tan, Li, Li, Zhou, Bao and He.

Use and reproduction: